Home Healthcare Biotechnology Blood Screening Market

Blood Screening Market Size, Share & Trends Analysis Report By Technology (Nucleic Acid Amplification Test (NAT), ELISA, Chemiluminescence Immunoassay (CLIA & EIA ), Next Generation Sequencing (NGS), Western Blotting (WB)), By Product (Reagent, Instrument) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Jay Mehta | Format: | Report Code: SR6030DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Blood Screening Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Nucleic Acid Amplification Test (NAT)
    2. ELISA
    3. Chemiluminescence Immunoassay (CLIA & EIA )
    4. Next Generation Sequencing (NGS)
    5. Western Blotting (WB)
  2. Blood Screening Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Reagent
    2. Instrument
  3. Regional Blood Screening Market
    1. North America
      1. North America Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
      2. North America Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
        1. Reagent
        2. Instrument
      3. U.S. Blood Screening Market
        1. U.S. Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. U.S. Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      4. Canada Blood Screening Market
        1. Canada Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Canada Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
    2. Europe
      1. Europe Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
      2. Europe Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
        1. Reagent
        2. Instrument
      3. U.K. Blood Screening Market
        1. U.K. Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. U.K. Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      4. Germany Blood Screening Market
        1. Germany Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Germany Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      5. France Blood Screening Market
        1. France Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. France Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      6. Spain Blood Screening Market
        1. Spain Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Spain Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      7. Italy Blood Screening Market
        1. Italy Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Italy Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      8. Russia Blood Screening Market
        1. Russia Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Russia Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      9. Nordic Blood Screening Market
        1. Nordic Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Nordic Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      10. Benelux Blood Screening Market
        1. Benelux Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Benelux Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      11. Rest of Europe Blood Screening Market
        1. Rest of Europe Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Rest of Europe Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
    3. APAC
      1. APAC Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
      2. APAC Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
        1. Reagent
        2. Instrument
      3. China Blood Screening Market
        1. China Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. China Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      4. Korea Blood Screening Market
        1. Korea Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Korea Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      5. Japan Blood Screening Market
        1. Japan Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Japan Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      6. India Blood Screening Market
        1. India Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. India Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      7. Australia Blood Screening Market
        1. Australia Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Australia Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      8. Singapore Blood Screening Market
        1. Singapore Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Singapore Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      9. Taiwan Blood Screening Market
        1. Taiwan Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Taiwan Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      10. South East Asia Blood Screening Market
        1. South East Asia Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. South East Asia Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      11. Rest of Asia-Pacific Blood Screening Market
        1. Rest of Asia-Pacific Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Rest of Asia-Pacific Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
    4. Middle East and Africa
      1. Middle East and Africa Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
      2. Middle East and Africa Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
        1. Reagent
        2. Instrument
      3. UAE Blood Screening Market
        1. UAE Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. UAE Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      4. Turkey Blood Screening Market
        1. Turkey Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Turkey Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      5. Saudi Arabia Blood Screening Market
        1. Saudi Arabia Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Saudi Arabia Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      6. South Africa Blood Screening Market
        1. South Africa Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. South Africa Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      7. Egypt Blood Screening Market
        1. Egypt Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Egypt Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      8. Nigeria Blood Screening Market
        1. Nigeria Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Nigeria Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      9. Rest of MEA Blood Screening Market
        1. Rest of MEA Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Rest of MEA Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
    5. LATAM
      1. LATAM Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
      2. LATAM Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
        1. Reagent
        2. Instrument
      3. Brazil Blood Screening Market
        1. Brazil Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Brazil Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      4. Mexico Blood Screening Market
        1. Mexico Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Mexico Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      5. Argentina Blood Screening Market
        1. Argentina Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Argentina Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      6. Chile Blood Screening Market
        1. Chile Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Chile Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      7. Colombia Blood Screening Market
        1. Colombia Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Colombia Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
      8. Rest of LATAM Blood Screening Market
        1. Rest of LATAM Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Nucleic Acid Amplification Test (NAT)
          2. ELISA
          3. Chemiluminescence Immunoassay (CLIA & EIA )
          4. Next Generation Sequencing (NGS)
          5. Western Blotting (WB)
        2. Rest of LATAM Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
          1. Reagent
          2. Instrument
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.